• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Posterior scleritis--an unusual manifestation of Cogan's syndrome.

作者信息

Shah P, Luqmani R A, Murray P I, Honan W P, Corridan P G, Emery P

机构信息

Birmingham and Midland Eye Hospital.

出版信息

Br J Rheumatol. 1994 Aug;33(8):774-5. doi: 10.1093/rheumatology/33.8.774.

DOI:10.1093/rheumatology/33.8.774
PMID:8055208
Abstract

Cogan's syndrome is characterized by a non-luetic interstitial keratitis associated with vertigo, tinnitus and profound deafness. Evidence of a systemic vasculitis is found in up to 50% of patients. Atypical forms of Cogan's syndrome have been described in which the ocular inflammatory disease may be more severe. We describe a case of atypical Cogan's syndrome in association with bilateral posterior scleritis. Serial B-scan ultrasound measurements of posterior scleral thickness were found to be useful in assessing disease activity, in combination with clinical findings. Combination therapy with prednisolone and cyclosporin controlled the ocular disease but the deafness was irreversible. The length of follow-up of this case highlights the frequent relapses and difficult management problems which may be faced. This multisystem disease requires the close co-operation of ophthalmologist, physician and otorhinolaryngologist. Aggressive therapeutic intervention with high-dose combined immunosuppressive agents may be necessary to control severe ocular inflammatory disease.

摘要

相似文献

1
Posterior scleritis--an unusual manifestation of Cogan's syndrome.
Br J Rheumatol. 1994 Aug;33(8):774-5. doi: 10.1093/rheumatology/33.8.774.
2
Early corneal findings in Cogan's syndrome.科根综合征的早期角膜表现。
Ophthalmology. 1984 Aug;91(8):903-7. doi: 10.1016/s0161-6420(84)34215-4.
3
[Cogan I syndrome: clinical aspects, therapy and prognosis].[科根综合征:临床症状、治疗与预后]
Ophthalmologe. 2000 Mar;97(3):197-202. doi: 10.1007/s003470050514.
4
Cogan's syndrome: ophthalmic, audiovestibular, and systemic manifestations and therapy.科根综合征:眼部、听觉前庭及全身表现与治疗
Int Ophthalmol Clin. 1996 Winter;36(1):61-72. doi: 10.1097/00004397-199603610-00008.
5
Cogan's syndrome: auditory and medical management.科根综合征:听觉及医疗管理
J Am Acad Audiol. 1992 May;3(3):225-9.
6
[Cogan's syndrome].[科根综合征]
Harefuah. 1978 Dec 15;95(12):422-6.
7
Posterior scleritis in Cogan's syndrome.科根综合征中的后巩膜炎。
Ocul Immunol Inflamm. 2004 Jun;12(2):149-52. doi: 10.1080/09273940490895362.
8
Cogan's syndrome: a cause of progressive hearing deafness.科根综合征:进行性听力丧失的一个病因。
Am J Otolaryngol. 2006 Jan-Feb;27(1):68-70. doi: 10.1016/j.amjoto.2005.07.006.
9
[Cogan's syndrome].[科根综合征]
Pol Arch Med Wewn. 2003 Mar;109(3):293-7.
10
[Cogan's Syndrome: case report].[柯根综合征:病例报告]
Arq Bras Oftalmol. 2005 Nov-Dec;68(6):850-2. doi: 10.1590/s0004-27492005000600026.

引用本文的文献

1
Ocular Manifestations in Patients with Sensorineural Hearing Loss.感音神经性听力损失患者的眼部表现
J Ophthalmic Vis Res. 2022 Nov 29;17(4):551-573. doi: 10.18502/jovr.v17i4.12321. eCollection 2022 Oct-Dec.
2
Fever of unknown origin, bilateral sensorineural hearing loss with canal paresis and uveitis with iridocyclitis and episcleritis: a case of Cogan's syndrome.不明原因发热、伴有半规管轻瘫的双侧感音神经性听力损失以及伴有虹膜睫状体炎和巩膜外层炎的葡萄膜炎:1例科根综合征病例
BMJ Case Rep. 2018 Apr 27;2018:bcr-2018-224535. doi: 10.1136/bcr-2018-224535.
3
Interstitial Keratitis, Vertigo, and Vasculitis: Typical Cogan's Syndrome.
间质性角膜炎、眩晕与血管炎:典型的科根综合征
Case Rep Med. 2014;2014:830831. doi: 10.1155/2014/830831. Epub 2014 Mar 4.
4
Cogan's syndrome: present and future directions.
Rheumatol Int. 2009 Aug;29(10):1117-21. doi: 10.1007/s00296-009-0945-0. Epub 2009 May 27.
5
Cystoid macular oedema in Cogans syndrome-a case report.科根综合征中的黄斑囊样水肿——病例报告
Cases J. 2008 Nov 20;1(1):339. doi: 10.1186/1757-1626-1-339.